First-time isolation and characterization of a bacteriophage encoding the Shiga toxin 2c variant, which is globally spread in strains of Escherichia coli O157.
A bacteriophage encoding the Shiga toxin 2c variant (Stx2c) was isolated from the human Escherichia coli O157 strain CB2851 and shown to form lysogens on the E. coli K-12 laboratory strains C600 and MG1655. Production of Stx2c was found in the wild-type E. coli O157 strain and the K-12 lysogens and was inducible by growing bacteria in the presence of ciprofloxacin. Phage 2851 is the first reported viable bacteriophage which carries an stx(2c) gene. Electron micrographs of phage 2851 showed particles with elongated hexagonal heads and long flexible tails resembling phage lambda. Sequence analysis of an 8.4-kb region flanking the stx(2c) gene and other genetic elements revealed a mosaic gene structure, as found in other Stx phages. Phage 2851 showed lysis of E. coli K-12 strains lysogenic for Stx phages encoding Stx1 (H19), Stx2 (933W), Stx (7888), and Stx1c (6220) but showed superinfection immunity with phage lambda, presumably originating from the similarity of the cI repressor proteins of both phages. Apparently, phage 2851 integrates at a different chromosomal locus than Stx2 phage 933W and Stx1 phage H19 in E. coli, explaining why Stx2c is often found in combination with Stx1 or Stx2 in E. coli O157 strains. Diagnostic PCR was performed to determine gene sequences specific for phage 2851 in wild-type E. coli O157 strains producing Stx2c. The phage 2851 q and o genes were frequently detected in Stx2c-producing E. coli O157 strains, indicating that phages related to 2851 are associated with Stx2c production in strains of E. coli O157 that were isolated in different locations and time periods.
Strauch
Eckhard
E
Division of Microbial Toxins, Department of Biological Safety, Robert Koch Institute, Nordufer 20, D-13353 Berlin, Germany.
Schaudinn
Christoph
C
Beutin
Lothar
L
D000942:Antigens, Bacterial; D001483:Base Sequence; D002772:Cholera Toxin; D022121:Cholera Vaccines; D002939:Ciprofloxacin / Q000494:pharmacology; D003090:Coliphages / Q000235:genetics*; D019453:Escherichia coli O157 / Q000821:virology*; D016679:Genome, Viral; D008969:Molecular Sequence Data; D009693:Nucleic Acid Hybridization; D016133:Polymerase Chain Reaction; D022641:Shiga Toxin 2 / Q000096:biosynthesis / Q000235:genetics*; D016662:Virus Integration
D000942:Antigens, Bacterial; D022121:Cholera Vaccines; C068569:E coli O18 O-specific polysaccharide-cholera toxin; D022641:Shiga Toxin 2; D002939:Ciprofloxacin; D002772:Cholera Toxin